Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exome-Wide Association Study of Pancreatic Cancer Risk.
Grant RC, Denroche RE, Borgida A, Virtanen C, Cook N, Smith AL, Connor AA, Wilson JM, Peterson G, Roberts NJ, Klein AP, Grimmond SM, Biankin A, Cleary S, Moore M, Lemire M, Zogopoulos G, Stein L, Gallinger S. Grant RC, et al. Among authors: moore m. Gastroenterology. 2018 Feb;154(3):719-722.e3. doi: 10.1053/j.gastro.2017.10.015. Epub 2017 Oct 24. Gastroenterology. 2018. PMID: 29074453 Free PMC article.
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
Brade A, Brierley J, Oza A, Gallinger S, Cummings B, Maclean M, Pond GR, Hedley D, Wong S, Townsley C, Brezden-Masley C, Moore M. Brade A, et al. Among authors: moore m. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1027-36. doi: 10.1016/j.ijrobp.2006.10.015. Epub 2006 Dec 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17197132 Clinical Trial.
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W; National Cancer Institute of Canada Clinical Trials Group. Moore MJ, et al. J Clin Oncol. 2007 May 20;25(15):1960-6. doi: 10.1200/JCO.2006.07.9525. Epub 2007 Apr 23. J Clin Oncol. 2007. PMID: 17452677 Clinical Trial.
Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.
Ryan P, Nanji S, Pollett A, Moore M, Moulton CA, Gallinger S, Guindi M. Ryan P, et al. Among authors: moore m. Am J Surg Pathol. 2010 Jun;34(6):784-91. doi: 10.1097/PAS.0b013e3181dc242c. Am J Surg Pathol. 2010. PMID: 20421779
Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.
Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, Wilson S, Moore M, Narod S, Jhaveri K, Haider MA, Gallinger S. Al-Sukhni W, et al. Among authors: moore m. J Gastrointest Surg. 2012 Apr;16(4):771-83. doi: 10.1007/s11605-011-1781-6. Epub 2011 Nov 30. J Gastrointest Surg. 2012. PMID: 22127781
Outcome of adjuvant therapy in biliary tract cancers.
McNamara MG, Walter T, Horgan AM, Amir E, Cleary S, McKeever EL, Min T, Wallace E, Hedley D, Krzyzanowska M, Moore M, Gallinger S, Greig P, Serra S, Dawson LA, Knox JJ. McNamara MG, et al. Among authors: moore m. Am J Clin Oncol. 2015 Aug;38(4):382-7. doi: 10.1097/COC.0b013e31829e19fb. Am J Clin Oncol. 2015. PMID: 24572429
7,522 results